TrialInternational journal of molecular sciences2025

Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Subgroup Insights from an Interventional Study.

Miloš Mitrović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.